Chromosomal aberrations in thyroid follicular-cell neoplasia: In the search of novel oncogenes and tumour suppressor genes

Molecular and Cellular Endocrinology

Volumn 321, Issue 1, 2010, Pages 57-66

  Zitzelsberger, Horst ^a   Thomas, Gerry ^b   Unger, Kristian ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Array CGH; Array painting; Chromosome; Copy number alteration; FISH; Follicular cell neoplasia; Next generation sequencing; Oncogene; Rearrangement; Tumour suppressor gene

Indexed keywords

CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DNA MICROARRAY; DNA SEQUENCE; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC MARKER; HUMAN; MOLECULAR BIOLOGY; ONCOGENE; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID CARCINOGENESIS; THYROID FOLLICULAR CELL NEOPLASIA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; ANIMALS; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; GENES, TUMOR SUPPRESSOR; HUMANS; ONCOGENES; THYROID NEOPLASMS;

EID: 77950937060     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.11.014     Document Type: Review

References (102)

1. Al-Brahim N., Asa S.L. Papillary thyroid carcinoma: an overview. Arch. Pathol. Lab. Med. 2006, 130:1057-1062.
2. Bashir A., Volik S., Collins C., Bafna V., Raphael B.J. Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer. PLoS Comput. Biol. 2008, 4:e1000051.
3. Basolo F., Pisaturo F., Pollina L.E., Fontanini G., Elisei R., Molinaro E., Iacconi P., Miccoli P., Pacini F. N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 2000, 10:19-23.
4. Bongarzone I., Fugazzola L., Vigneri P., Mariani L., Mondellini P., Pacini F., Basolo F., Pinchera A., Pilotti S., Pierotti M.A. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1996, 81:2006-2009.
5. Bounacer A., Wicker R., Caillou B., Cailleux A.F., Sarasin A., Schlumberger M., Suarez H.G. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997, 15:1263-1273.
6. Carvalho B., Ouwerkerk E., Meijer G.A., Ylstra B. High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides. J. Clin. Pathol. 2004, 57:644-646.
7. Castro P., Roque L., Magalhaes J., Sobrinho-Simoes M. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation. Int. J. Surg. Pathol. 2005, 13:235-238.
8. Chen X., Knauf J.A., Gonsky R., Wang M., Lai E.H., Chissoe S., Fagin J.A., Korenberg J.R. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am. J. Hum. Genet. 1998, 63:625-637.
9. Chiacchio S., Lorenzoni A., Boni G., Rubello D., Elisei R., Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol. 2008, 33:341-357.
10. Ciampi R., Knauf J.A., Kerler R., Gandhi M., Zhu Z., Nikiforova M.N., Rabes H.M., Fagin J.A., Nikiforov Y.E. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J. Clin. Invest. 2005, 115:94-101.
11. Ciampi R., Nikiforov Y.E. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 2007, 148:936-941.
12. Cohen Y., Xing M., Mambo E., Guo Z., Wu G., Trink B., Beller U., Westra W.H., Ladenson P.W., Sidransky D. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 2003, 95:625-627.
13. Corvi R., Berger N., Balczon R., Romeo G. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene 2000, 19:4236-4242.
14. Dettori T., Frau D.V., Lai M.L., Mariotti S., Uccheddu A., Daniele G.M., Tallini G., Faa G., Vanni R. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations. Genes Chromosomes Cancer 2003, 38:22-31.
15. Elisei R., Romei C., Vorontsova T., Cosci B., Veremeychik V., Kuchinskaya E., Basolo F., Demidchik E.P., Miccoli P., Pinchera A., et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J. Clin. Endocrinol. Metab. 2001, 86:3211-3216.
16. Fiegler H., Carr P., Douglas E.J., Burford D.C., Hunt S., Scott C.E., Smith J., Vetrie D., Gorman P., Tomlinson I.P., et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003, 36:361-374.
17. Fiegler H., Redon R., Andrews D., Scott C., Andrews R., Carder C., Clark R., Dovey O., Ellis P., Feuk L., et al. Accurate and reliable high-throughput detection of copy number variation in the human genome. Genome Res. 2006, 16:1566-1574.
18. Finn S., Smyth P., O'Regan E., Cahill S., Toner M., Timon C., Flavin R., O'Leary J., Sheils O. Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines. Arch. Pathol. Lab. Med. 2007, 131:65-73.
19. Frau D.V., Lai M.L., Caria P., Dettori T., Coni P., Faa G., Morandi L., Tallini G., Vanni R. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings. J. Clin. Endocrinol. Metab. 2008, 93:177-181.
20. Fugazzola L., Pierotti M.A., Vigano E., Pacini F., Vorontsova T.V., Bongarzone I. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 1996, 13:1093-1097.
21. Fugazzola L., Pilotti S., Pinchera A., Vorontsova T.V., Mondellini P., Bongarzone I., Greco A., Astakhova L., Butti M.G., Demidchik E.P., et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 1995, 55:5617-5620.
22. Garcia-Rostan G., Costa A.M., Pereira-Castro I., Salvatore G., Hernandez R., Hermsem M.J., Herrero A., Fusco A., Cameselle-Teijeiro J., Santoro M. Mutation of the PIK3CA gene in anaplastic thyroid cancer. Cancer Res. 2005, 65:10199-10207.
23. Giordano T.J., Kuick R., Thomas D.G., Misek D.E., Vinco M., Sanders D., Zhu Z., Ciampi R., Roh M., Shedden K., et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 2005, 24:6646-6656.
24. Guarino V., Faviana P., Salvatore G., Castellone M.D., Cirafici A.M., De Falco V., Celetti A., Giannini R., Basolo F., Melillo R.M., et al. Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. J. Clin. Endocrinol. Metab. 2005, 90:5270-5278.
25. Hamatani K., Eguchi H., Ito R., Mukai M., Takahashi K., Taga M., Imai K., Cologne J., Soda M., Arihiro K., et al. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Res. 2008, 68:7176-7182.
26. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
27. Hemmer S., Wasenius V.M., Knuutila S., Franssila K., Joensuu H. DNA copy number changes in thyroid carcinoma. Am. J. Pathol. 1999, 154:1539-1547.
28. Hemmer S., Wasenius V.M., Knuutila S., Joensuu H., Franssila K. Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization. Br. J. Cancer 1998, 78:1012-1017.
29. Herrmann M.A., Hay I.D., Bartelt D.H., Ritland S.R., Dahl R.J., Grant C.S., Jenkins R.B. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J. Clin. Invest. 1991, 88:1596-1604.
30. Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 1990, 9:811-818.
31. Jazdzewski K., Murray E.L., Franssila K., Jarzab B., Schoenberg D.R., de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7269-7274.
32. Jenkins R.B., Hay I.D., Herath J.F., Schultz C.G., Spurbeck J.L., Grant C.S., Goellner J.R., Dewald G.W. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 1990, 66:1213-1220.
33. Kallioniemi O.P., Kallioniemi A., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin. Cancer Biol. 1993, 4:41-46.
34. Kimura E.T., Nikiforova M.N., Zhu Z., Knauf J.A., Nikiforov Y.E., Fagin J.A. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003, 63:1454-1457.
35. Kitamura Y., Shimizu K., Tanaka S., Ito K., Emi M. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma. Clin. Cancer Res. 2000, 6:1819-1825.
36. Klugbauer S., Demidchik E.P., Lengfelder E., Rabes H.M. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Res. 1998, 58:198-203.
37. Klugbauer S., Lengfelder E., Demidchik E.P., Rabes H.M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995, 11:2459-2467.
38. Klugbauer S., Rabes H.M. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999, 18:4388-4393.
39. Kondo T., Ezzat S., Asa S.L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 2006, 6:292-306.
40. Kroll T.G., Sarraf P., Pecciarini L., Chen C.J., Mueller E., Spiegelman B.M., Fletcher J.A. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 2000, 289:1357-1360.
41. Lee J.J., Au A.Y., Foukakis T., Barbaro M., Kiss N., Clifton-Bligh R., Staaf J., Borg A., Delbridge L., Robinson B.G., et al. Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocr. Relat. Cancer 2008, 15:801-815.
42. Lee J.J., Foukakis T., Hashemi J., Grimelius L., Heldin N.E., Wallin G., Rudduck C., Lui W.O., Hoog A., Larsson C. Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models. Thyroid 2007, 17:289-301.
43. Lemoine N.R., Mayall E.S., Wyllie F.S., Williams E.D., Goyns M., Stringer B., Wynford-Thomas D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989, 4:159-164.
44. Lima J., Trovisco V., Soares P., Maximo V., Magalhaes J., Salvatore G., Santoro M., Bogdanova T., Tronko M., Abrosimov A., et al. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004, 89:4267-4271.
45. Lu C.M., Kwan J., Baumgartner A., Weier J.F., Wang M., Escudero T., Munne S., Zitzelsberger H.F., Weier H.U. DNA probe pooling for rapid delineation of chromosomal breakpoints. J. Histochem. Cytochem. 2009, 57:587-597.
46. Manenti G., Pilotti S., Re F.C., Della Porta G., Pierotti M.A. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur. J. Cancer 1994, 30A:987-993.
47. Mardis E.R. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 2008, 9:387-402.
48. Mark J., Ekedahl C., Dahlenfors R., Westermark B. Cytogenetical observations in five human anaplastic thyroid carcinomas. Hereditas 1987, 107:163-174.
49. Marques A.R., Espadinha C., Catarino A.L., Moniz S., Pereira T., Sobrinho L.G., Leite V. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J. Clin. Endocrinol. Metab. 2002, 87:3947-3952.
50. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat. Res. 2000, 462:247-253.
51. Miura D., Wada N., Chin K., Magrane G.G., Wong M., Duh Q.Y., Clark O.H. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization. Thyroid 2003, 13:283-290.
52. Musholt P.B., Musholt T.J., Morgenstern S.C., Worm K., Sheu S.Y., Schmid K.W. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. World J. Surg. 2008, 32:722-728.
53. Nakata T., Kitamura Y., Shimizu K., Tanaka S., Fujimori M., Yokoyama S., Ito K., Emi M. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. Genes Chromosomes Cancer 1999, 25:97-103.
54. Namba H., Rubin S.A., Fagin J.A. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol. 1990, 4:1474-1479.
55. Nappi T.C., Salerno P., Zitzelsberger H., Carlomagno F., Salvatore G., Santoro M. Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. Cancer Res. 2009, 69:1916-1923.
56. Nikiforov Y.E. RET/PTC rearrangement in thyroid tumors. Endocr. Pathol. 2002, 13:3-16.
57. Nikiforova M.N., Ciampi R., Salvatore G., Santoro M., Gandhi M., Knauf J.A., Thomas G.A., Jeremiah S., Bogdanova T.I., Tronko M.D., et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett. 2004, 209:1-6.
58. Nikiforova M.N., Lynch R.A., Biddinger P.W., Alexander E.K., Dorn G.W., Tallini G., Kroll T.G., Nikiforov Y.E. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J. Clin. Endocrinol. Metab. 2003, 88:2318-2326.
59. Parente F., Gaudray P., Carle G.F., Turc-Carel C. Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridization CGH. Cytogenet. Cell Genet. 1997, 78:65-68.
60. Pierotti M.A., Bongarzone I., Borello M.G., Greco A., Pilotti S., Sozzi G. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer 1996, 16:1-14.
61. Pierotti M.A., Santoro M., Jenkins R.B., Sozzi G., Bongarzone I., Grieco M., Monzini N., Miozzo M., Herrmann M.A., Fusco A., et al. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:1616-1620.
62. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 1998, 20:207-211.
63. Port M., Boltze C., Wang Y., Roper B., Meineke V., Abend M. A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers. Radiat. Res. 2007, 168:639-649.
64. Powell N., Jeremiah S., Morishita M., Dudley E., Bethel J., Bogdanova T., Tronko M., Thomas G. Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure. J. Pathol. 2005, 205:558-564.
65. Rhoden K.J., Unger K., Salvatore G., Yilmaz Y., Vovk V., Chiappetta G., Qumsiyeh M.B., Rothstein J.L., Fusco A., Santoro M., et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J. Clin. Endocrinol. Metab. 2006, 91:2414-2423.
66. Richter H., Braselmann H., Hieber L., Thomas G., Bogdanova T., Tronko N., Zitzelsberger H. Chromosomal imbalances in post-chernobyl thyroid tumors. Thyroid 2004, 14:1061-1064.
67. Ringel M.D., Hayre N., Saito J., Saunier B., Schuppert F., Burch H., Bernet V., Burman K.D., Kohn L.D., Saji M. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res. 2001, 61:6105-6111.
68. Rippe V., Drieschner N., Meiboom M., Murua Escobar H., Bonk U., Belge G., Bullerdiek J. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 2003, 22:6111-6114.
69. Rodrigues R.F., Roque L., Krug T., Leite V. Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines. Br. J. Cancer 2007, 96:1237-1245.
70. Roque L., Castedo S., Gomes P., Soares P., Clode A., Soares J. Cytogenetic findings in 18 follicular thyroid adenomas. Cancer Genet. Cytogenet. 1993, 67:1-6.
71. Roque L., Nunes V.M., Ribeiro C., Martins C., Soares J. Karyotypic characterization of papillary thyroid carcinomas. Cancer 2001, 92:2529-2538.
72. Roque L., Rodrigues R., Pinto A., Moura-Nunes V., Soares J. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas. Genes Chromosomes Cancer 2003, 36:292-302.
73. Sadetzki S., Calderon-Margalit R., Modan B., Srivastava S., Tuttle R.M. Ret/PTC activation in benign and malignant thyroid tumors arising in a population exposed to low-dose external-beam irradiation in childhood. J. Clin. Endocrinol. Metab. 2004, 89:2281-2289.
74. Said S., Schlumberger M., Suarez H.G. Oncogenes and anti-oncogenes in human epithelial thyroid tumors. J. Endocrinol. Invest. 1994, 17:371-379.
75. Salassidis K., Bruch J., Zitzelsberger H., Lengfelder E., Kellerer A.M., Bauchinger M. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma. Cancer Res. 2000, 60:2786-2789.
76. Salvatore G., Nappi T.C., Salerno P., Jiang Y., Garbi C., Ugolini C., Miccoli P., Basolo F., Castellone M.D., Cirafici A.M., et al. A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Res. 2007, 67:10148-10158.
77. Santoro M., Carlomagno F., Hay I.D., Herrmann M.A., Grieco M., Melillo R., Pierotti M.A., Bongarzone I., Della Porta G., Berger N., et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J. Clin. Invest. 1992, 89:1517-1522.
78. Santoro M., Melillo R.M., Fusco A. RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur. J. Endocrinol. 2006, 155:645-653.
79. Schröck E., Veldman T., Padilla-Nash H., Ning Y., Spurbeck J., Jalal S., Shaffer L.G., Papenhausen P., Kozma C., Phelan M.C., et al. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum. Genet. 1997, 101:255-262.
80. Singh B., Lim D., Cigudosa J.C., Ghossein R., Shaha A.R., Poluri A., Wreesmann V.B., Tuttle M., Shah J.P., Rao P.H. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. Surgery 2000, 128:888-893. discussion 893-884.
81. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Dohner H., Cremer T., Lichter P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997, 20:399-407.
82. Speicher M.R., Gwyn Ballard S., Ward D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat. Genet. 1996, 12:368-375.
83. Szuhai K., Bezrookove V., Wiegant J., Vrolijk J., Dirks R.W., Rosenberg C., Raap A.K., Tanke H.J. Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. Genes Chromosomes Cancer 2000, 28:92-97.
84. Teixeira M.R. Recurrent fusion oncogenes in carcinomas. Crit. Rev. Oncog. 2006, 12:257-271.
85. Thomas G.A., Bunnell H., Cook H.A., Williams E.D., Nerovnya A., Cherstvoy E.D., Tronko N.D., Bogdanova T.I., Chiappetta G., Viglietto G., et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J. Clin. Endocrinol. Metab. 1999, 84:4232-4238.
86. Tuttle R.M., Lukes Y., Onstad L., Lushnikov E., Abrosimov A., Troshin V., Tsyb A., Davis S., Kopecky K.J., Francis G. ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout. Thyroid 2008, 18:839-846.
87. Unger K., Malisch E., Thomas G., Braselmann H., Walch A., Jackl G., Lewis P., Lengfelder E., Bogdanova T., Wienberg J., et al. Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 2008, 27:4592-4602.
88. Unger K., Zitzelsberger H., Salvatore G., Santoro M., Bogdanova T., Braselmann H., Kastner P., Zurnadzhy L., Tronko N., Hutzler P., et al. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004, 89:4272-4279.
89. Unger K., Zurnadzhy L., Walch A., Mall M., Bogdanova T., Braselmann H., Hieber L., Tronko N., Hutzler P., Jeremiah S., et al. RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. Br. J. Cancer 2006, 94:1472-1477.
90. van Beers E.H., Joosse S.A., Ligtenberg M.J., Fles R., Hogervorst F.B., Verhoef S., Nederlof P.M. A multiplex PCR predictor for aCGH success of FFPE samples. Br. J. Cancer 2006, 94:333-337.
91. van de Wiel M.A., van Wieringen W.N. CGHregions: dimension reduction for array CGH data with minimal information loss. Cancer Inform. 2007, 3:55-63.
92. van Wieringen W.N., van de Wiel M.A. Nonparametric testing for DNA copy number induced differential mRNA gene expression. Biometrics 2009, 65:19-29.
93. Venkatraman R., Raman R., Raman B., Moss R.B., Rubin G.D., Mathers L.H., Robinson T.E. Fully automated system for three-dimensional bronchial morphology analysis using volumetric multidetector computed tomography of the chest. J. Digit. Imaging 2007, 19:132-139.
94. Vitagliano D., Carlomagno F., Motti M.L., Viglietto G., Nikiforov Y.E., Nikiforova M.N., Hershman J.M., Ryan A.J., Fusco A., Melillo R.M., et al. Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. Cancer Res. 2004, 64:3823-3829.
95. Weier H.U., Tuton T.B., Ito Y., Chu L.W., Lu C.M., Baumgartner A., Zitzelsberger H.F., Weier J.F. Molecular cytogenetic characterization of chromosome 9-derived material in a human thyroid cancer cell line. Cytogenet Genome Res. 2006, 114:284-291.
96. Wilkens L., Benten D., Tchinda J., Brabant G., Potter E., Dralle H., von Wasielewski R. Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation. Virchows Arch. 2000, 436:312-318.
97. Williams E.D. Histogenesis of medullary carcinoma of the thyroid. J. Clin. Pathol. 1966, 19:114-118.
98. Wreesmann V.B., Ghossein R.A., Patel S.G., Harris C.P., Schnaser E.A., Shaha A.R., Tuttle R.M., Shah J.P., Rao P.H., Singh B. Genome-wide appraisal of thyroid cancer progression. Am. J. Pathol. 2002, 161:1549-1556.
99. Wu G., Mambo E., Guo Z., Hu S., Huang X., Gollin S.M., Trink B., Ladenson P.W., Sidransky D., Xing M. Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. J. Clin. Endocrinol. Metab. 2005, 90:4688-4693.
100. Yoon H., He H., Nagy R., Davuluri R., Suster S., Schoenberg D., Pellegata N., Chapelle Ade L. Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. Int. J. Cancer 2007, 121:767-775.
101. Zhu Z., Gandhi M., Nikiforova M.N., Fischer A.H., Nikiforov Y.E. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am. J. Clin. Pathol. 2003, 120:71-77.
102. Zitzelsberger H., Lehmann L., Hieber L., Weier H.U., Janish C., Fung J., Negele T., Spelsberg F., Lengfelder E., Demidchik E.P., et al. Cytogenetic changes in radiation-induced tumors of the thyroid. Cancer Res. 1999, 59:135-140.